North America Anticoccidial Drugs Industry by Drug type (Antibiotic anticoccidials, Ionophoreanticoccidials, Chemical derivative anticoccidials), by Animals (Poultry, Swine, Fish, Cattle and Companion animals.), and by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecast (2016 – 2021)
- Advertising -
According to the report North America Anticoccidial Drugs Industry, published by Market Data Forecast, The Industry is estimated to grow from $815.5 million in 2015 to $980 Million by 2020 at a CAGR of 3.4%.
With the ban on consumption of antibiotics as a source of animal feed and the upsurge in antibiotic resistant microbes has reduced the growth of the antibiotic Industry, nevertheless the rising incidence of coccidiosis over the time and its control on the overall cost to benefit ratio for the meat industry has increased the growth potential of anticoccidials drug Industry.
Browse Market data tables and in-depth TOC of the North America Anticoccidial Drugs Industry to 2021 at www.marketdataforecast.com/market-…-drugs-market-22/
Coccidiosis caused by coccidian protozoa, is a parasitic infection of the intestinal tract of animals. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue.
- Advertising -
It infects a wide variety of animals, such as cattle, poultry species, pigs and sheep. It can be responsible for devastating mislay in meat production.
To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
Growing demand for meat proteins is forcing the farmers, mainly in the developed countries to use various antibiotics for maintaining a quality production. Further, the trend of owning companion animals in these nations is increasing the expenditure on antibiotics, driving the North American anticoccidialIndustry.
The North America anticoccidial drugs Industry is classified based on various types of animals and by type of drugs. The animal segment is sub-categorised into poultry, swine, fish, cattle and companion animals.
The companion animal is further segmented into dogs and cats. The livestock segment has a greater potential compares to others.
In addition to this, the Industry is also analysed on the basis of drug type into antibiotic anticoccidials, Ionophoreanticoccidials and chemical derivative anticoccidials.
Furthermore, on the basis of geography, the North America Industry is analysed under various regions namely, USA and Canada. North America leads the global anticoccidial drugs Industry owing to increased preventive usage of anticoccidials in animal feed.
It contributes to around 24% of the worldwide Industry for anticoccidial drugs with U.S.A holding the largest Industry share for anticoccidial drugs followed by Canada.
Currently, the major players in the industry are facing complications with the rising incidences of microbial resistance build-up to anticoccidial drugs and government regulations in developed regions, which is compelling them to invest in emerging Industrys. Some of the key players operating in the Industry are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, BoehringerIngelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
North America Anticoccidial Drugs Industry: Segmentation
- By Drug Type
- o Antibiotic anticoccidials
- o Ionophoreanticoccidials
- o Chemical derivative anticoccidials
- By Animal Type
- o Poultry
- o Swine
- o Fish
- o Cattle
- o Companion Animal
- United States
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: